Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
VALN
VALN
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
VALN News
Valneva SE Under Investigation for Securities Fraud
6d ago
Globenewswire
Valneva SE Under Investigation for Securities Fraud
Apr 02 2026
PRnewswire
Pomerantz LLP Investigates Valneva for Securities Fraud
Mar 31 2026
Globenewswire
Biotech Landscape Update: Regulatory Approvals and Mergers
Mar 27 2026
NASDAQ.COM
Valneva to Participate in World Vaccine Congress 2026
Mar 26 2026
Newsfilter
Valneva's Vaccine Trial Fails to Meet Primary Endpoint
Mar 24 2026
Globenewswire
Valneva's Lyme Disease Vaccine Candidate Shows Over 70% Efficacy
Mar 23 2026
NASDAQ.COM
Experimental Lyme Disease Vaccine Shows Over 70% Efficacy
Mar 23 2026
Yahoo Finance
Pfizer and Valneva Report Phase 3 Results for Lyme Disease Vaccine
Mar 23 2026
seekingalpha
Pfizer and Valneva Report Phase 3 Vaccine Trial Results
Mar 23 2026
NASDAQ.COM
Pfizer's Vaccine Candidate PF-07307405 Shows Over 70% Efficacy
Mar 23 2026
Newsfilter
PFIZER AND VALNEVA REPORT STRONG EFFICACY OF LYME DISEASE VACCINE CANDIDATE IN PHASE 3 VALOR TRIAL
Mar 23 2026
moomoo
Valneva SE Reports 2024 Earnings Highlights
Mar 18 2026
Yahoo Finance
Elaris FlexCo Secures Exclusive Vaccine Technology Rights from Valneva
Mar 18 2026
seekingalpha
Elaris Secures Exclusive License from Valneva for CDI Vaccine Technology
Mar 18 2026
PRnewswire
Elaris Secures Exclusive License from Valneva for CDI Vaccine Technology
Mar 18 2026
Newsfilter
Show More News
